null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Zolbetuximab Biosimilar (Anti-CLDN18.2) Antibody (HDBS0069)

SKU HDBS0069
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CLDN18.2
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Zolbetuximab (Anti-CLDN18.2) Biosimilar Antibody (HDBS0069)

The Anti-CLDN18.2 (Zolbetuximab Biosimilar) Antibody (HDbs0069) is a valuable tool for researchers studying CLDN18.2, a tight junction protein involved in maintaining epithelial barrier integrity. This monoclonal antibody, produced in mice, exhibits high specificity and sensitivity for detecting CLDN18.2 in various samples, making it suitable for use in immunohistochemistry and flow cytometry applications.CLDN18.2 is known to be overexpressed in certain cancers, particularly gastric cancer, where it serves as a potential therapeutic target.

By targeting CLDN18.2, researchers can investigate the role of this protein in cancer progression and explore novel treatment strategies. The Anti-CLDN18.2 Antibody (HDbs0069) provides researchers with a reliable tool for investigating the biological function of CLDN18.2 and its potential as a target for precision medicine approaches in cancer therapy.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose